What Dermatologists Do: Scope of Practice and Specializations
Dermatology encompasses the diagnosis, medical management, and surgical treatment of conditions affecting the skin, hair, nails, and mucous membranes. The field spans more than 3,000 distinct diseases and conditions, ranging from common inflammatory disorders to malignant neoplasms. Understanding the scope of dermatologic practice clarifies when a dermatologist's expertise is required versus when a primary care physician can appropriately manage a skin complaint. This page covers the clinical scope, subspecialties, procedural toolkit, and the professional and regulatory boundaries that define dermatologic practice in the United States.
Definition and scope
Dermatology is a physician-level specialty recognized by the American Board of Dermatology (ABD), which has administered board certification examinations since 1932. Practitioners who complete the full training pathway and pass the ABD examination hold the designation of board-certified dermatologist — a distinction explored further on the Board Certification in Dermatology page.
The clinical scope defined by the ABD and the Accreditation Council for Graduate Medical Education (ACGME) encompasses four principal domains:
- Medical dermatology — diagnosis and systemic or topical treatment of inflammatory, infectious, autoimmune, and genetic skin diseases.
- Surgical dermatology — excisions, biopsies, Mohs micrographic surgery, laser procedures, and reconstruction.
- Cosmetic dermatology — elective procedures including injectables, chemical peels, and resurfacing that address aesthetic rather than pathological concerns.
- Dermatopathology — microscopic analysis of skin tissue specimens to confirm diagnoses, often performed in conjunction with surgical removal.
The regulatory context for dermatology in the United States is shaped by state medical practice acts, which govern licensure, prescribing authority, and the procedures physicians may perform. Because dermatologists hold a full medical license (MD or DO), their scope is not procedurally capped at the specialty level — state law defines the outer boundary for all physicians.
Skin accounts for approximately 16% of total body weight in the average adult (National Institutes of Health, MedlinePlus), and dermatologic conditions represent one of the most frequent reasons for outpatient physician visits in the United States. The National Ambulatory Medical Care Survey (NAMCS), administered by the CDC's National Center for Health Statistics, has consistently ranked skin disorders among the top 20 diagnostic categories in outpatient settings.
How it works
A dermatologic encounter follows a structured clinical pathway that integrates visual examination, patient history, and confirmatory testing.
Step 1 — Visual and dermoscopic examination. The primary diagnostic instrument in dermatology is direct inspection. Dermoscopy, a technique using a handheld illuminated magnifier, extends unaided visual resolution and is addressed in detail on Dermoscopy and Skin Imaging.
Step 2 — Lesion characterization. Dermatologists apply a standardized morphological vocabulary — macule, papule, plaque, vesicle, pustule, nodule, wheal — to classify lesions before proposing diagnoses. This shared lexicon is codified in the ABD's content outline for the certifying examination.
Step 3 — Confirmatory diagnostics. Depending on presentation, the physician may order:
- Skin biopsy (shave, punch, excisional, or incisional) — see Skin Biopsy: What to Expect
- Patch testing for allergic contact dermatitis — see Patch Testing for Allergies
- Fungal cultures, KOH preparations, or Wood's lamp examination
- Serology or genetic panels for systemic autoimmune conditions
Step 4 — Treatment planning. The treatment toolkit spans topical agents (corticosteroids, retinoids, antibiotics, calcineurin inhibitors), systemic medications (immunosuppressants, biologics, oral retinoids), and procedural interventions. Biologics now approved by the FDA for conditions including moderate-to-severe plaque psoriasis and atopic dermatitis represent one of the fastest-growing categories in dermatologic pharmacology.
Step 5 — Surveillance and follow-up. Chronic conditions such as psoriasis, eczema, and rosacea require longitudinal management. Malignancy cases require staged follow-up aligned with guidelines from organizations including the National Comprehensive Cancer Network (NCCN) and the American Academy of Dermatology (AAD).
Common scenarios
Dermatologists manage conditions that fall into five broad clinical categories, each with distinct diagnostic and treatment demands.
Inflammatory skin disease — Atopic dermatitis, psoriasis, rosacea, and seborrheic dermatitis collectively account for a large proportion of dermatology outpatient volume. Psoriasis alone affects approximately 7.5 million adults in the United States (AAD, Psoriasis Statistics).
Skin cancer detection and treatment — Melanoma, basal cell carcinoma (BCC), and squamous cell carcinoma (SCC) are the three primary malignant categories. The AAD estimates that 9,500 people are diagnosed with skin cancer in the United States every day. BCC is the most frequently diagnosed cancer in the country by total case volume. Mohs micrographic surgery, detailed on Mohs Surgery Explained, achieves cure rates above 99% for primary BCC in low-risk anatomic locations, according to the AAD's published clinical data.
Infectious skin conditions — Bacterial folliculitis, tinea infections, herpes zoster, molluscum contagiosum, and warts fall within dermatologic scope. Fungal Skin Infections covers the diagnostic and treatment framework for dermatophyte conditions specifically.
Hair and nail disorders — Alopecia areata, androgenetic alopecia, onychomycosis, and nail psoriasis require dermatologic evaluation. These are addressed in Alopecia and Hair Loss and Nail Disorders and Dermatology.
Occupational and contact dermatoses — Workplace exposure to irritants and allergens produces a distinct pattern of skin disease governed in part by OSHA standards (29 CFR Part 1910) and addressed in Occupational Skin Conditions.
Decision boundaries
A core competency in dermatology is distinguishing conditions that fall within the specialty's scope from those requiring co-management or referral to other disciplines.
Dermatologist versus general practitioner — Primary care physicians routinely manage uncomplicated acne, mild tinea infections, and common warts. Dermatologic referral is generally indicated when: a diagnosis is uncertain after initial evaluation, first-line treatments have failed, a lesion is suspicious for malignancy, or a systemic condition with cutaneous manifestations requires specialist coordination. The Dermatologist vs. General Practitioner page maps these boundary cases in detail.
Medical versus cosmetic dermatology — The distinction between medical and cosmetic services carries direct insurance coverage implications. Medically necessary procedures — biopsies, treatment of active disease, skin cancer surgery — are typically covered under health insurance subject to policy terms. Elective cosmetic procedures — botulinum toxin for aesthetic purposes, filler injections, purely cosmetic laser resurfacing — are generally not covered. Cosmetic vs. Medical Dermatology and Dermatology Insurance and Coverage address these distinctions in depth.
Dermatology subspecialties — The ACGME recognizes formal fellowship training in 3 dermatologic subspecialties: dermatopathology, pediatric dermatology, and micrographic surgery and dermatologic oncology. Clinical immunodermatology and procedural dermatology represent additional areas of concentrated practice without separate ACGME accreditation status. Full subspecialty profiles are provided on Dermatology Subspecialties.
Scope limits and interprofessional boundaries — Systemic conditions that produce cutaneous findings — lupus erythematosus, dermatomyositis, sarcoidosis — frequently require concurrent management by rheumatology or pulmonology. Pediatric presentations with complex genetics may involve clinical genetics consultation alongside pediatric dermatology, a subspecialty documented in Pediatric Dermatology Conditions.
For a broad orientation to skin disease categories and how they align with dermatologic subspecialty expertise, the site index provides a structured entry point across all clinical topics covered in this reference.
References
- American Board of Dermatology (ABD)
- Accreditation Council for Graduate Medical Education (ACGME) — Dermatology Program Requirements
- American Academy of Dermatology (AAD) — Statistics
- AAD — Psoriasis Statistics
- [U.S. Food and Drug Administration (FDA) — Drugs](https://www.f
The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)